We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Global ELISA Analyzers Market Driven by Demand for Technologically Advanced Immunological Tools

By LabMedica International staff writers
Posted on 30 Oct 2023
Print article
Image: The global ELISA analyzers market is expected to register an impressive CAGR during the 2024-2028 forecast period (Photo courtesy of 123RF)
Image: The global ELISA analyzers market is expected to register an impressive CAGR during the 2024-2028 forecast period (Photo courtesy of 123RF)

Enzyme-Linked Immunosorbent Assay, commonly known as ELISA, is a laboratory test used for detecting antibodies in the blood. ELISA tests operate on the interaction between antibodies and antigens, making it useful for diagnosing diseases. Automated instruments, or analyzers, carry out various steps of the test, ensuring both accuracy and consistent results. As the incidence of diseases like cancer, hepatitis, and HIV rises globally, there is a growing need for diagnostic tools like ELISA, thereby boosting the market for ELISA analyzers. The global ELISA analyzers market is projected to grow at an impressive rate from 2024 to 2028, due to the increasing demand for reliable infectious disease tests and the growing need for technologically advanced diagnostic tools.

These are the latest findings of Research and Markets (Ireland, UK), a provider of market research reports.

Analyzers are engineered to meet specific requirements for running immunological tests, such as maintaining test sensitivity, reducing background noise, and ensuring quick and consistent outcomes. Some modern ELISA analyzers, like open-system automated analyzers, come with pre-set testing options and easy-to-follow guides, simplifying the setup process and making it more convenient for users. Innovations in automation, like increased walkaway time and throughput, are also minimizing the labor-intensive aspects of handling large samples, which is anticipated to further drive market growth in the coming years.

In addition, their ability to measure enzyme activity and detect soluble proteins and cytokines is also increasing the demand for ELISA analyzers. The rise in allergy cases is spurring a need for diagnostic techniques, including ELISA, which is frequently employed for identifying food allergies. The indirect IgE-ELISA method is commonly used for detecting specific allergen-related IgE in blood serum due to its cost-effectiveness and simplicity compared to other systems. ELISA also has applications in measuring antibody levels used for assessing vaccine effectiveness, resulting in growing demand from companies that are at the forefront of vaccine development.

Related Links:
Research and Markets

Platinum Supplier
Xylazine Immunoassay Test
Xylazine ELISA
Gold Supplier
ESR Analyzer
miniiSED™
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Cardiac Test
Fluoro-Check AMI 3 IN 1

Print article

Channels

Clinical Chemistry

view channel
Image: A module with eight micro-devices, complete with microfluidic channels and drive motors (Photo courtesy of U.S Department of Energy)

Highly Sensitive pH Sensor to Aid Detection of Cancers and Vector-Borne Viruses

Understanding the acidity or alkalinity of substances through pH measurement is crucial in many fields, from environmental monitoring to healthcare product safety. In many cases, these measurements must... Read more

Molecular Diagnostics

view channel
Image: The PrismRA blood test helps target best treatments for patients with rheumatoid arthritis (Photo courtesy of Scipher Medicine)

Groundbreaking Rheumatoid Arthritis Blood Test Predicts Treatment Response

Rheumatoid arthritis (RA), an autoimmune disease affecting joints and other systems in the body, impacts millions globally. Typically, the initial biologic treatment involves anti-inflammatory drugs from... Read more

Hematology

view channel
Image: The QScout hematology analyzer has received US FDA 510(k) clearance (Photo courtesy of Ad Astra Diagnostics)

First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC

Sepsis, a critical medical condition that arises as an extreme response to infection, poses a significant health threat. It occurs when an infection triggers a widespread inflammatory response in the body.... Read more

Immunology

view channel
Image: PointCheck is the world’s first device for non-invasive white cell monitoring (Photo courtesy of Leuko Labs)

World’s First Portable, Non-Invasive WBC Monitoring Device to Eliminate Need for Blood Draw

One of the toughest challenges for cancer patients undergoing chemotherapy is experiencing a low count of white blood cells, also known as neutropenia. These cells play a crucial role in warding off infections.... Read more

Microbiology

view channel
Image: Current testing methods for antibiotic susceptibility rely on growing bacterial colonies in the presence of antibiotics (Photo courtesy of 123RF)

Rapid Antimicrobial Susceptibility Test Returns Results within 30 Minutes

In 2019, antimicrobial resistance (AMR) was responsible for the deaths of approximately 1.3 million individuals. The conventional approach for testing antimicrobial susceptibility involves cultivating... Read more

Pathology

view channel
Image: AI methods used in satellite imaging can help researchers analyze tumor images (Photo courtesy of Karolinska Institutet)

AI Approach Combines Satellite Imaging and Ecology Techniques for Analysis of Tumor Tissue

Advancements in tumor imaging technology have significantly enhanced our ability to observe the minute details of tumors, but this also brings the challenge of interpreting vast amounts of data generated... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.